jump to content

Fachbereich Veterinärmedizin


Service-Navigation

    Publication Database

    Heteroresistance in Enterobacter cloacae complex caused by variation in transient gene amplification events (2025)

    Art
    Zeitschriftenartikel / wissenschaftlicher Beitrag
    Autoren
    Kupke, Johannes (WE 7)
    Brombach, Julian (WE 7)
    Fang, Yuwen
    Wolf, Silver A.
    Thrukonda, Lakshmipriya
    Ghazisaeedi, Fereshteh (WE 7)
    Kuropka, Benno
    Hanke, Dennis (WE 7)
    Semmler, Torsten
    Nordholt, Niclas
    Schreiber, Frank
    Tedin, Karsten (WE 7)
    Lübke-Becker, Antina (WE 7)
    Steiner, Ulrich K.
    Fulde, Marcus (WE 7)
    Quelle
    npj antimicrobials and resistance
    Bandzählung: 3
    Heftzählung: 1
    Seiten: Artikel 13
    ISSN: 2731-8745
    Sprache
    Englisch
    Verweise
    URL (Volltext): https://www.nature.com/articles/s44259-025-00082-7
    DOI: 10.1038/s44259-025-00082-7
    Pubmed: 39987221
    Kontakt
    Institut für Mikrobiologie und Tierseuchen

    Robert-von-Ostertag-Str. 7-13
    14163 Berlin
    +49 30 838 51843 / 66949
    mikrobiologie@vetmed.fu-berlin.de

    Abstract / Zusammenfassung

    Heteroresistance (HR) in bacteria describes a subpopulational phenomenon of antibiotic resistant cells of a generally susceptible population. Here, we investigated the molecular mechanisms and phenotypic characteristics underlying HR to ceftazidime (CAZ) in a clinical Enterobacter cloacae complex strain (ECC). We identified a plasmid-borne gene duplication-amplification (GDA) event of a region harbouring an ampC gene encoding a β-lactamase blaDHA-1 as the key determinant of HR. Individual colonies exhibited variations in the copy number of the genes resulting in resistance level variation which correlated with growth onset (lag times) and growth rates in the presence of CAZ. GDA copy number heterogeneity occurred within single resistant colonies, demonstrating heterogeneity of GDA on the single-cell level. The interdependence between GDA, lag time and antibiotic treatment and the strong plasticity underlying HR underlines the high risk for misdetection of antimicrobial HR and subsequent treatment failure.